Inventor · disambiguated record
Christian Gerdes
Also filed as: GERDES CHRISTIAN
4 granted patents·14 pending applications·85 citations·filing 2009–2020
78Inventor score
Top patents by PatentIndex Score
18 records- 0196US9526797B2Combination IL-2 immunoconjugate therapyROCHE GLYCART AG·Filed 2013·Granted Dec 27, 2016·57 cites·20 claims
- 0293US10603360B2Combination IL-2 immunoconjugate therapyROCHE GLYCART AG·Filed 2016·Granted Mar 31, 2020·13 cites·22 claims
- 0388US9180185B2Combination therapy of anti-HER3 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Nov 10, 2015·13 cites·15 claims
- 0470US9360481B2Predictive biomarker for cancer treatment with ADCC-enhanced antibodiesROCHE GLYCART AG·Filed 2014·Granted Jun 7, 2016·2 cites·7 claims
- 0564US2020197492A1Combination il-2 immunoconjugate therapyROCHE GLYCART AG·Filed 2020·Application pending·0 cites
- 0660US2014065097A1ImmunotherapyROCHE GLYCART AG·Filed 2013·Application pending·0 cites
- 0759US2010081796A1Bispecific anti-egfr/anti-igf-1r antibodiesBRINKMANN ULRICH·Filed 2009·Application pending·0 cites
- 0855US2012258073A1ImmunotherapyGERDES CHRISTIAN·Filed 2012·Application pending·0 cites
- 0953US2020095313A1Combination therapy of antibodies activating human cd40 and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1048US2018051077A1Combination therapy of antibodies activating human cd40 and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 1145US2012149879A1Bispecific anti-egfr/anti-igf-1r antibodiesBRINKMANN ULRICH·Filed 2011·Application pending·0 cites
- 1245US2022031871A1Antibodies for chelated radionuclides and clearing agentsHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1342US2016058891A1In vivo adcc modelROCHE GLYCART AG·Filed 2012·Application pending·0 cites
- 1442US2016045597A1Combination therapy of antibodies activating human cd40 and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1541US2016159912A1Combination therapy of anti-her3 antibodiesHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1639US2013273032A1Predictive biomarker for cancer treatment with adcc-enhanced antibodiesROCHE GLYCART AG·Filed 2013·Application pending·0 cites
- 1739US2013195854A1Predictive biomarker for cancer treatment with adcc-enhanced antibodiesROCHE GLYCART AG·Filed 2013·Application pending·0 cites
- 1838US2011200595A1TREATMENT WITH A HUMANIZED IgG CLASS ANTI EGFR ANTIBODY AND AN ANTIBODY AGAINST INSULIN LIKE GROWTH FACTOR 1 RECEPTORRoche Glycart·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →